Bland–Altman plot for ASDAS-Q and ASDAS-CRP. ASDAS, Ankylosing

Bland-Altman plot for ASDAS-qCRP and ASDAS-CRP

Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study, BMC Musculoskeletal Disorders

Bland–Altman plot for ASDAS-Q and ASDAS-CRP. ASDAS, Ankylosing

Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia. - Abstract - Europe PMC

Full article: Abstract of the 35th Scandinavian Congress of Rheumatology, Stockholm, Sweden, September 20th – 23rd, 2014

Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability, Health and Quality of Life Outcomes

FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining the Best Calculation Method When the Conventional C-Reactive Protein (CRP) is below the Threshold of Detection - Results from the DESIR Cohort

Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study - ACR Meeting Abstracts

Disease Control Data, Ankylosing Spondylitis

Standard Error: Most Up-to-Date Encyclopedia, News & Reviews

Improved Performance of Compartments in Detecting the Activity of Axial Spondyloarthritis Based on IVIM DWI with Optimized Threshold Value

Bland–Altman plot for ASDAS-Q and ASDAS-CRP. ASDAS, Ankylosing

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO, Arthritis Research & Therapy

Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention

PDF) The Value of the Ankylosing Spondylitis Disease Activity Score (Asdas) in Evaluating Disease Activity in Patients with Axial Spondyloarthritis